Lysyl hydroxylase 2 glucosylates collagen VI to drive lung cancer progression
Journal of Clinical Investigation · 01.04.2025 · 135 (7)
DOI: 10.1172/jci189197 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 01.04.2025. Verfasst von Shike Wang und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic/Head and Neck Medical Oncology, The University of Texas-MD Anderson Cancer Center, Houston, Texas, USA. Hauptthemen laut MEDLINE: Lung Neoplasms, Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase, Collagen Type VI, Neoplasm Proteins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Lysyl hydroxylase 2 (LH2) is highly expressed in multiple tumor types and accelerates disease progression by hydroxylating lysine residues on fibrillar collagen telopeptides to generate stable collagen cross links in tumor stroma. Here, we show that a galactosylhydroxylysyl glucosyltransferase (GGT) domain on LH2 modified type-VI collagen (Col6) to promote lung adenocarcinoma (LUAD) growth and metastasis. In tumors generated by LUAD cells lacking LH2 GGT domain activity, stroma was less stiff, and stable types of collagen cross links were reduced. Mass spectrometric analysis of total and glycosylated peptides in parental and GGT-inactive tumor samples identified Col6 chain α3 (Col6a3), a component of the Col6 heterotrimeric molecule, as a candidate LH2 substrate. In gain- and loss-of-function studies, high Col6a3 levels increased tumor growth and metastatic activity and enhanced the proliferative, migratory, and invasive activities of LUAD cells. LH2 coimmunoprecipitated with Col6a3, and LH2 glucosylated Col6 in an in vitro reaction. Glucosylation increased the integrin-binding and promigratory activities of Col6 in LUAD cells. Col6a3 K2049 was deglucosylated in GGT-inactive tumor samples, and mutagenesis of Col6a3 K2049 phenocopied Col6a3 deficiency or LH2 GGT domain inactivation in LUAD cells. Thus, LH2 glucosylates Col6 to drive LUAD progression. These findings show that the GGT domain of LH2 is protumorigenic, identify Col6 as a candidate effector, and provide a rationale to develop pharmacological strategies that target LH2’s GGT domain in cancer cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thoracic/Head and Neck Medical Oncology, The University of Texas-MD Anderson Cancer Center, Houston, Texas, USA.
- Department of Molecular and Cellular Biochemistry, University of Kentucky, Lexington, Kentucky, USA.
- Department of Biomedical Sciences, Adams School of Dentistry, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
- Department of Molecular and Cellular Oncology, Division of Basic Science Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
- Department of Toxicology and Cancer Biology, The University of Kentucky, Lexington, Kentucky, USA.
- Cell and Molecular Biology, University of St Thomas, Houston, Texas, USA.
Förderung
- NCI NIH HHS
Zitieren
APA
Wang, S., Guo, H., Fukushima, R., Terajima, M., Liu, M., Xiao, G. Y., Koudelková, L., Wu, C., Liu, X., Yu, J., Burris, E., Xu, J., Schiavinato, A., Russell, W. K., Yamauchi, M., Tan, X., & Kurie, J. M. (2025). Lysyl hydroxylase 2 glucosylates collagen VI to drive lung cancer progression. Journal of Clinical Investigation, 135(7). https://doi.org/10.1172/jci189197
Vancouver
Wang S, Guo H, Fukushima R, Terajima M, Liu M, Xiao GY, et al. Lysyl hydroxylase 2 glucosylates collagen VI to drive lung cancer progression. Journal of Clinical Investigation. 2025;135(7). doi:10.1172/jci189197
BibTeX
@article{Wang2025,
author = {Wang, Shike and Guo, Houfu and Fukushima, Reo and Terajima, Masahiko and Liu, Min and Xiao, Guan-Yu and Koudelková, Lenka and Wu, Chao and Liu, Xin and Yu, Jiang and Burris, Emma and Xu, Jun and Schiavinato, Alvise and Russell, William K and Yamauchi, Mitsuo and Tan, Xiaochao and Kurie, Jonathan M},
title = {Lysyl hydroxylase 2 glucosylates collagen VI to drive lung cancer progression},
journal = {Journal of Clinical Investigation},
year = {2025},
volume = {135},
number = {7},
doi = {10.1172/jci189197}
}
EUVIMED